🇺🇸 medication 1 in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 10

Most-reported reactions

1. Abdominal Pain — 1 report (10%)
2. Blood Pressure Decreased — 1 report (10%)
3. Blood Pressure Increased — 1 report (10%)
4. Body Height Decreased — 1 report (10%)
5. Bronchitis — 1 report (10%)
6. Cataract — 1 report (10%)
7. Chest Discomfort — 1 report (10%)
8. Connective Tissue Disorder — 1 report (10%)
9. Cough — 1 report (10%)
10. Covid-19 — 1 report (10%)

Source database →

Frequently asked questions

Is medication 1 approved in United States?

medication 1 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for medication 1 in United States?

Instituto Materno Infantil Prof. Fernando Figueira is the originator. The local marketing authorisation holder may differ — check the official source linked above.